nav menu
close nav
background
background

NEWS

26 February 2024

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine

26 February 2024

Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect<sup>®</sup> Platform’s Versatility

4 October 2023

Innovation City: Emerging with the Innovation Award was Akston Biosciences Corp., which proposes once-a-week insulin injections for diabetic cats and dogs.

7 September 2023

Protein Therapeutics to Amp Up Outsourcing in Animal Health

6 September 2023

Akston Biosciences wins Innovation Award at Animal Health Summit

5 September 2023

Todd Zion, PhD “More Magical Proteins”

5 September 2023

Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5%

4 September 2023

Akston Chooses Pet Health Over Human Medicine

1 September 2023

Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit

31 August 2023

Akston Biosciences Wins Innovation Award At KC Animal Health Summit